Aleksandra Kovacevic
Overview
Explore the profile of Aleksandra Kovacevic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jacevic V, Dragojevic-Simic V, Tatomirovic Z, Dobric S, Bokonjic D, Kovacevic A, et al.
Int J Mol Sci
. 2018 Aug;
19(8).
PMID: 30103540
Amifostine is well known cytoprotector which is efficient when administered before a wide range of antineoplastic agents. The aim of our study was to investigate amifostine effects on doxorubicin-induced toxic...
12.
Miljkovic M, Dragojevic-Simic V, Rancic N, Simic R, Pekez-Pavlisko T, Kovacevic A, et al.
Front Public Health
. 2018 Aug;
6:213.
PMID: 30094229
Metamizole is a medication with analgesic, antipyretic, spasmolytic, and weak anti-inflammatory effects. The aim of our study was to evaluate a six-year trend in the utilization and expenditure of metamizole...
13.
Dragojevic-Simic V, Kovacevic A, Jacevic V, Rancic N, Djordjevic S, Kilibarda V, et al.
Expert Opin Drug Metab Toxicol
. 2018 Jul;
14(9):979-988.
PMID: 30028640
Background: The aim of the study was to evaluate the bioequivalence of two itraconazole 100 mg capsule formulations. Research Design And Methods: The single-center, open-label, randomized, three-period, three-sequence, reference-replicated, cross-over...
14.
Harrison J, Waters J, Biddulph T, Kovacevic A, Klok C, Socha J
J Insect Physiol
. 2017 Sep;
106(Pt 3):189-198.
PMID: 28927826
While it is clear that the insect tracheal system can respond in a compensatory manner to both hypoxia and hyperoxia, there is substantial variation in how different parts of the...
15.
Kovacevic A, Rancic N, Segrt Z, Dragojevic-Simic V
Front Pharmacol
. 2016 Oct;
7:373.
PMID: 27790144
No abstract available.
16.
Rancic N, Dragojevic-Simic V, Vavic N, Kovacevic A, Segrt Z, Djordjevic N
Front Public Health
. 2016 Sep;
4:189.
PMID: 27630984
Renal transplantation is the treatment of choice for the patients with end-stage renal failure. Genetic factors, among others, can influence variability in response to immunosuppressive drugs. Nowadays, due to restrictive...
17.
Jakovljevic M, Vukovic M, Chen C, Antunovic M, Dragojevic-Simic V, Velickovic-Radovanovic R, et al.
Balkan Med J
. 2016 Mar;
33(1):8-17.
PMID: 26966613
Background: Serbia, as the largest market of the Western Balkans, has entered socioeconomic transition with substantial delay compared to most of Eastern Europe. Its health system reform efforts were bold...
18.
Mugosa S, Bukumiric Z, Kovacevic A, Boskovic A, Protic D, Todorovic Z
Vojnosanit Pregl
. 2016 Jan;
72(11):975-81.
PMID: 26731971
Background/aim: Adverse drug reactions (ADRs) appear more frequently than actually reported and registered. The main goal of our work was to analyze risk factors, incidence and characteristics of ADRs in...
19.
Rancic N, Dragojevic-Simic V, Vavic N, Kovacevic A, Segrt Z, Draskovic-Pavlovic B, et al.
Vojnosanit Pregl
. 2015 Nov;
72(9):813-22.
PMID: 26554114
Unlabelled: BACKGROUND/AIM. A combination of tacrolimus and other drugs such as corticosteroids has been commonly used immunosuppressive regimens. On the other hand, there is a growing body of evidence that...
20.
Kovacevic A, Dragojevic-Simic V, Tarabar D, Rancic N, Jacimovic N, Katic J, et al.
Expert Rev Anticancer Ther
. 2015 Jun;
15(8):963-70.
PMID: 26089093
Aim: To evaluate the costs and survival estimates of metastatic colorectal carcinoma patients treated with conventional cytostatic protocols and adjuvant monoclonal antibodies (mAbs). Methods: Retrospective randomized case series and cost-of-illness...